Healthcare-associated infections and antimicrobial use in acute care hospitals in Greece, 2022; results of the third point prevalence survey

被引:5
作者
Palaiopanos, Konstantinos [1 ]
Krystallaki, Dimitra [1 ]
Mellou, Kassiani [1 ]
Kotoulas, Petros [1 ]
Kavakioti, Christina-Anna [1 ]
Vorre, Styliani [1 ]
Vertsioti, Georgia [1 ]
Gkova, Maria [1 ]
Maragkos, Antonios [1 ]
Tryfinopoulou, Kyriaki [2 ]
Paraskevis, Dimitrios [1 ,3 ]
Tsiodras, Sotirios [1 ,4 ]
Zaoutis, Theoklis [1 ,5 ]
机构
[1] Natl Publ Hlth Org EODY, Directorate Epidemiol Surveillance & Intervent Inf, Athens, Greece
[2] Natl Publ Hlth Org, Cent Publ Hlth Lab, Athens, Greece
[3] Natl & Kapodistrian Univ Athens, Med Sch, Dept Hyg Epidemiol & Med Stat, Athens, Greece
[4] Natl & Kapodistrian Univ Athens, Attikon Univ Hosp, Dept Internal Med 4, Athens, Greece
[5] Natl & Kapodistrian Univ Athens, P&A Kyriakou Childrens Hosp, Dept Pediat 2, Athens, Greece
关键词
Point prevalence survey; Infections; HAIs; Antimicrobials; Prescription; Stewardship; Inpatients; Prevalence; Greece; CLINICAL-PRACTICE GUIDELINES;
D O I
10.1186/s13756-024-01367-8
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
BackgroundThe burden of healthcare-associated infections (HAIs) and the extent of antimicrobial use (AU) are periodically recorded through Point Prevalence Surveys (PPS) in acute care hospitals coordinated by the European Centre for Disease Prevention and Control (ECDC). In previous PPSs, Greece demonstrated increased HAI and AU prevalence: 9% and 54.7% in 2011-2012, and 10% and 55.6% in 2016-2017, respectively. The 2022 PPS aimed to estimate HAIs and AU indicators among inpatients, especially amid the COVID-19 pandemic.MethodsA cross-sectional study was conducted in 50 hospitals during October-December 2022, in Greece. Patients admitted before 8.00 a.m. of the survey day were observed. Patients with at least one HAI or receiving at least one antimicrobial agent were included. Data were collected by hospital infection control teams. Hospital and ward-level variables were analysed.ResultsFrom 9,707 inpatients, 1,175 had at least one HAI (12.1%), and 5,376 were receiving at least one antimicrobial (55.4%). Intensive care unit patients had the highest HAI (45.7%) and AU (71.3%) prevalence. Of the 1,408 recorded HAIs, lower respiratory tract (28.9%), bloodstream (20%), and urinary tract infections (13.1%) were the most common. Among 1,259 isolates, Klebsiella (20.5%) and Acinetobacter (12.8%) were most frequently identified. Resistance to first-level antibiotic markers was 69.3%. Among the 9,003 antimicrobials, piperacillin-tazobactam (10.9%), and meropenem (7.7%) were frequently prescribed. The ratio of broad-spectrum to narrow-spectrum antibiotics was 1.4. As defined by the 2021 WHO AWaRe (Access, Watch, Reserve) classification, restricted classes of Watch and Reserve agents comprised 76.7% of antibiotics. Usual indications were treatment of community-acquired infections (34.6%) and HAIs (22.9%). For surgical prophylaxis, cefoxitin was commonly used (20.2%), and typical courses (75.7%) lasted more than one day. HAI and AU prevalence were positively associated with bed occupancy (p = 0.027) and secondary hospitals (p = 0.014), respectively.ConclusionsThe 2022 PPS highlighted the increasing trend of HAI prevalence and high AU prevalence in Greece, the emergence of difficult-to-treat pathogens, and the extensive use of broad-spectrum antimicrobials. Strengthening infection control and antimicrobial stewardship programs in hospital settings is essential.
引用
收藏
页数:11
相关论文
共 28 条
  • [1] Access, 2022, Watch, Reserve) antibiotic book
  • [2] Strategies to Prevent Surgical Site Infections in Acute Care Hospitals: 2014 Update
    Anderson, Deverick J.
    Podgorny, Kelly
    Berrios-Torres, Sandra I.
    Bratzler, Dale W.
    Dellinger, E. Patchen
    Greene, Linda
    Nyquist, Ann-Christine
    Saiman, Lisa
    Yokoe, Deborah S.
    Maragakis, Lisa L.
    Kaye, Keith S.
    [J]. INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY, 2014, 35 (06) : 605 - 627
  • [3] [Anonymous], 2022, The Rational Choice Antimicrobial Therapy for the Hospitalized Patient
  • [4] [Anonymous], 2013, Point prevalence survey of healthcare associated infections and antimicrobial use in European acute care hospitals
  • [5] [Anonymous], 2015, Global Action Plan on Antimicrobial Resistance
  • [6] [Anonymous], 2019, WHO releases the 2019 AWaRe Classification Antibiotics
  • [7] [Anonymous], 2022, Number of hospital beds, inpatients, and patient-days in Greek hospitals
  • [8] Antimicrobial resistance surveillance in, 2023, Europe 20232021 data
  • [9] Association of Duration and Type of Surgical Prophylaxis With Antimicrobial-Associated Adverse Events
    Branch-Elliman, Westyn
    O'Brien, William
    Strymish, Judith
    Itani, Kamal
    Wyatt, Christina
    Gupta, Kalpana
    [J]. JAMA SURGERY, 2019, 154 (07) : 590 - 598
  • [10] Clinical Practice Guidelines for Antimicrobial Prophylaxis in Surgery
    Bratzler, Dale W.
    Dellinger, E. Patchen
    Olsen, Keith M.
    Perl, Trish M.
    Auwaerter, Paul G.
    Bolon, Maureen K.
    Fish, Douglas N.
    Napolitano, Lena M.
    Sawyer, Robert G.
    Slain, Douglas
    Steinberg, James P.
    Weinstein, Robert A.
    [J]. SURGICAL INFECTIONS, 2013, 14 (01) : 73 - 156